Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX EBITDA

EBITDA at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$161M-20.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$108.66M-3.1%
ALN
Alnylam PharmaceuticalsALNY
$282.19M+769%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Arrowhead Research logo
Arrowhead ResearchARWR
——

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

−$701.6Mebit+
$1.1MDepreciation Depletion & Amortization
=-$700.54M

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's EBITDA?
BioCryst Pharmaceuticals (BCRX) reported EBITDA of -$700.54M in Q1 2026.
How has BioCryst Pharmaceuticals's EBITDA changed year-over-year?
BioCryst Pharmaceuticals's EBITDA decreased by 3349.5% year-over-year, from $21.56M to -$700.54M.
What is the long-term trend for BioCryst Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's EBITDA has grown at a 17.9% compound annual growth rate (CAGR), from -$176.94M to $342.38M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.